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                                                       ABSTRACT 
Introduction: 
Bacterial vaginosis is a polymicrobial syndrome characterized by replacement of 
normal vaginal Lactobacilli into pathogenic mycoplasms and Gram negative rods. 
It is the most common cause of vaginal discharge in reproductive age group. Most 
commonly used methods for diagnosis of BV are Amsel’s criteria and Nugent’s 
score. 
Aims & Objectives: 
The aim of this study is to study the prevalence of Bacterial vaginosis and to 
compare the efficacy of Amsel’s criteria and Nugent’s score in diagnosing BV. 
Methodology: 
This study was conducted in Institute of Venereology, Madras Medical College, 
Chennai. 100 female patients attending STD op were included in the study. 
Subjects were evaluated for the presence of Bacterial vaginosis by Amsel’s criteria 
and Nugent’s score. 
Results: 
In our study, the prevalence of Bacterial vaginosis by Nugent’s score was 51% and 
by Amsel’s criteria was 77%.Among the individual components of Amsel’s 
criteria, whiff test had the highest specificity and clue cells >20% had the highest 
sensitivity. 
Conclusion: 
Amsel’s criteria being a simple and inexpensive method, it can be used as a 
method of diagnosing Bacterial vaginosis where the laboratory facilities are 
inadequate. Nugent’s score requires infrastructure facilities with skilled manpower 
and thus it can be used as a diagnostic method in Tertiary Care Centre. 
 
Keywords: Bacterial vaginosis, Nugent’s score, Amsel’s criteria 
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INTRODUCTION 
 
Bacterial vaginosis (BV) is the most prevalent cause of vaginal 
symptoms among women of childbearing age. 
 
It represents complex and unique change in the vaginal flora, which 
is characterized by a reduction in the number and prevalence of lactobacilli 
and with an increase in the concentration of Gardnerella vaginalis and 
other anaerobic bacteria. Majority of the women with Bacterial vaginosis 
are asymptomatic, but some present with foul smelling, thin, 
homogeneous, frothy, vaginal discharge.(65)  
 
         The vaginal microbial ecosystem is disturbed in BV. But whether 
Bacterial vaginosis is a true tissue or epithelial infection is unclear. 
Women with Bacterial vaginosis are at increased risk of chorioamnionitis, 
prematurity during pregnancy, pelvic inflammatory disease (PID), and 
pelvic infection following gynecological or obstetric surgery, and mostly, 
acquisition of genital herpes2 and human papillomavirus. 
 
         As Bacterial vaginosis is just an overgrowth of the normal vaginal 
flora without inflammation, there is no single best method for the diagnosis 
of Bacterial vaginosis. Most often, multiple criteria are used for the 
diagnosis of Bacterial vaginosis.  
  
 
 
Review of Literature 
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REVIEW OF LITERATURE 
 
ANATOMY OF VAGINA 
Vagina is an elastic lumen about 7.5cm long. The elastic nature of 
the vagina is due to its fibro muscular structure. The lumen has three layers  
 
• Outer layer  - which consists of areolar tissue. 
• Middle layer - which consists of smooth muscle. 
• Inner layer - which consists of non keratinized stratified squamous                                
epithelium. 
 
Vagina extends from cervix above to vaginal orifice below. It has 
anterior and posterior walls. Normally anterior wall of vagina is shorter 
than the posterior wall. The anterior wall is about 3 inches whereas the 
posterior wall is 3-5 inches long. Anteriorly the vagina is related to bladder 
and urethra and posteriorly it is related to pouch of Douglas, ampulla of 
rectum, perineal body. Laterally it is related to ureter, levator ani muscle, 
urogenital diaphragm and bulb of vestibule. The anterior wall of which is 
pierced by the cervix which usually projects downward and backward. The 
vaginal lumen that surrounds the cervix is divided into four regions or 
fornices – anterior, posterior, right lateral, left lateral. The vagina runs 
obliquely upwards and backwards at an angle of 450. Vaginal orifice in 
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virgin is usually covered by a thin membrane of connective tissue called 
the hymen which is perforated in the centre. When the hymen ruptures it 
remains as small tags or carunculae hymenales.(1) 
 
VAGINAL MICROBIOME 
The micro-organisms which colonize the vagina are collectively 
termed as the vaginal microbiota or vaginal microflora. In 1892 German 
gynecologist Albert Doderlein first described the normal vaginal flora. In 
his study he first described about the facultative anaerobic Gram-positive 
bacteria that were later called “Döderlein's bacilli” or Lactobacilli and, in 
bacterial taxonomy they are classified into the genus Lactobacillus.(2) 
 
 
Fig.a- Lactobacillus 
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Lactobacillus constitutes about 96% of total vaginal flora. Other 
microbes are Bifidobacterium, Peptostreptococcus, Porphyromonas, 
Prevotella bivia, Propionibacterium propionicus, Mobilincus species, 
Gardnerella vaginalis, Genital mycoplasmas, Staphylococci, Streptococci, 
Corynebacterium species, Yeast, etc.(8) 
 
Lactobacilli are present usually at a concentration of 105 – 108 
colony forming units (CFU) /ml of  vaginal fluid in normal females. Most 
common species is Lactobacillus acidophilus. Other species are 
L.crispatus, L.jensenii, L.fermentum, L.casei, L.cellobiosus, L.oris, 
L.gesseri, L.reuteri, L.vaginalis, L.iners, etc. 
 
SENTINEL EFFECT OF LACTOBACILLUS                                  
Vagina is a microbiological battleground. Lactobacillus acts as 
guard of vagina. Lactobacillus adheres to the vaginal epithelium, resulting 
in long term colonization of the vagina which prevents the adherence of 
other pathogenic bacteria. In addition to this it also produces lactic acid, 
hydrogen peroxide (H2O2) and other antimicrobial products. 
 
• Lactic acid – 
          The glycogen which is deposited on the vaginal wall under the 
influence of estrogen is converted into glucose. The glucose in turn is 
converted into lactic acid by the action of lactobacilli which changes the 
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vaginal pH to acidic. The acidic pH of the vagina prevents the colonization 
of other pathogenic microbes. 
 
•  Hydrogen peroxide –  
          It is mainly produced by L.crispatus and L.jensenii. It acts directly 
via the toxic action of H2O2, or through H2O2 – halide – peroxidase 
antibacterial system by reacting with halide ion in the presence of cervical 
peroxidase enzyme. It inhibits the growth of Gardnerella vaginalis, HIV, 
HSV – 2, Trichomonas vaginalis, Prevotella bivia and E.coli. It also 
inhibits catalase activity of Neisseria gonorrheae by forming a combination 
of acid peroxide and protein inhibitors of catalase activity. 
 
• Bacteriocins –  
         These are the anti-microbial substances produced by Lactobacilli 
which includes lactacin B and lactocidin.(2) The protective role of these 
substances is not well established. 
 
The newborn has a sterile vagina and it starts acquiring the 
microbial flora within 24 hours after birth. These microbial flora are 
diverse and they depend upon the pH and enzyme content of the female 
genital tract during different phases of life. Usually the micrococci, 
enterococci & diphtheroids invade the vagina within few hours after birth. 
In about 2 -3 days of life, under the influence of maternal estrogen 
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glycogen get deposited in the vaginal epithelium which facilitates the 
growth of lactobacilli and in few weeks the flora resembles that of adults. 
In prepubertal girls, the glycogen deposition is less which leads to reduced 
colonization of lactobacilli and they predominantly contain anaerobic rods 
and cocci. During the reproductive period the estrogen surge occurs, which 
makes vaginal pH more acidic there by favouring the growth of 
lactobacillus predominantly. In postmenopausal women without hormone 
replacement theraphy, the colonization of lactobacillus reduces to 50%. In 
these persons Prevotella, Gardnerella and genital Mycoplasma are very 
rarely seen.  
 
The physiological conditions that alter normal vaginal flora are 
pregnancy, menstruation and sexual intercourse. In pregnancy there is mild 
elevation of lactobacilli counts and mild decrease in anaerobes. Less 
number of lactobacilli is seen during menstruation. During sexual 
intercourse there will be an increase in vaginal pH which favours the entry 
of various organisms like E.coli and group B Streptococci.  However there 
is no change in Lactobacilli count. 
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LIFE TIME CHANGES IN VAGINAL pH 
There is usually a striking relationship between lifecycle of the 
individual and the vaginal pH levels. The vaginal pH is estrogen 
dependant. As estrogen level increases vaginal pH becomes acidic. 
 
Normal vaginal pH in different age group is as shown below: 
• New born – 5.7 
• Pre pubertal girls – 6 to 8 
• Puberty – 4 to 4.5 
• Pregnancy – 4 to 4.5 
• Reproductive life – 4 to 4.5 
• Menopause – greater than 7. 
 
During menstruation the pH of the vagina increases to six on day 
two. Subsequently there is a fall in pH on day four and pH by that time 
becomes four. These changes in the vaginal environment during 
menstruation lead to drastic changes in ecology of vaginal flora. In a study 
conducted among Chinese women which was published in journal of 
obstetrics and gynecology res in 2009 they have observed that the 
lactobacillus is the predominant organism maintaining the vaginal pH.(9) 
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VAGINAL DISCHARGE 
Vagina is lined by stratified squamous epithelium and there are no 
sweat, sebaceous and other secretory glands. Vaginal secretion is mainly a 
serum transudate which comes out of the intercellular channels in the 
vaginal capillaries. Vaginal transudate mainly composed of cellular debris 
(sloughed cervical columnar and vaginal squamous epithelial cells), water, 
electrolytes, facultative micro organisms, fatty acids, proteins, and 
carbohydrates. Another main source of vaginal secretion is from the 
cervical glands. They are tubuloalveolar glands which secretes thick and 
viscid mucus. There is minor contribution from Bartholin’s glands, 
endometrium and Fallopian tubes.  
 
          Normal vaginal discharge is whitish, clear, non offensive, floccular 
in consistency that may vary with menstrual cycle with pH ranges from 3.5 
to 4.5. The vaginal epithelial cells contain lot of estrogen receptors. The 
activity of these receptors depends upon the hormonal cycle. During 
midcycle of menstruation the estrogen level increases. This leads to 
increased proliferation of vaginal epithelial cells and increased deposition 
of glycogen. With increase in estrogen level, the mucus secretion also 
increases but the viscosity of the mucus decreases leading to more watery 
discharge. In the late follicular phase of the cycle the secretion increases 30 
folds.(1) 
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Abnormal vaginal discharge is considered if any one of the following three 
characteristic features is present  
 
1. Excessive vaginal discharge not associated with 
menstruation(pre/mid/post  menstrual ) 
2. Foul smelling or malodorous discharge 
3. Yellowish discharge.(3) 
 
CAUSES OF ABNORMAL VAGINAL DISCHARGE 
        The causes for abnormal vaginal discharge can be physiological or 
pathological. The pathological causes for vaginal discharge can be due to 
infection or other noninfective causes.  
 
PHYSIOLOGICAL 
• Neonates and infants 
•  Prepubertal age    
• Pregnancy   
• Child bearing 
• Post menopausal 
• Sexual arousal 
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PATHOLOGICAL 
 
It can be infective and noninfective: 
 Noninfective causes: 
1. Chemical irritants 
• Detergents  
• Deodorants 
• Antiseptics 
• Spermicides  
• Douches 
 
2. Foreign bodies 
• IUCD 
• Retained tampons 
•  Retained materials  
• Retained sheets 
 
3. Gynecological conditions 
• Endocervical polyps 
• Fistulae 
• Radiation effects 
• Post operative  
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• Tumors 
• Medications 
• Sexual practice 
 
Noninfective causes: 
1. Cervicitis  
• Herpes genitalis 
• Gonococcal cervicitis 
• Chlamydial cervicitis 
 
2. Vaginitis  
• Bacterial vaginosis 
• Vaginal Candidasis 
• Vaginal Trichomoniasis 
 
BACTERIAL VAGINOSIS 
Synonym:  
 Non specific vaginitis, hemophilus / corynebacterium / Gardnerella 
vaginitis, Non specific vaginosis, Hemophilus vaginalis vaginitis, Vaginal 
bacteriosis. 
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Bacterial vaginosis is a polymicrobial syndrome characterized by 
replacement of normal vaginal lactobacilli by a variety of anaerobic 
bacteria and mycoplasms mainly Gardnerella vaginalis, Mobiluncus 
species, Mycoplasma hominis, and anaerobic Gram-negative rods which 
belongs to the genera Bacteroides, Prevotella, Porphyromonas, 
Peptostreptococcus species and sometimes Leptotricha,  Atopobium 
vaginae, Megasphaera, Eggerthella and Dialister. BV is the most common 
cause of abnormal vaginal discharge.(5) It is vaginosis rather than vaginitis, 
as it does not cause inflammation, but only alteration in microbial flora. 
 
BACTERIAL TAXONOMY 
 
GARDNERELLA VAGINALIS 
Kingdom Bacteria 
Phylum Actinobacteria 
Class Actinobacteria 
Order Bifidobacteriales 
Family Bifidobacteriaceae 
Genus Gardnerella 
Species G.vaginalis 
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 Gardnerella vaginalis is a gram variable bacterium otherwise called 
gram intermediate bacteria. It is non motile coccobacilli. They are 
pleomorphic rods that don’t contain typical capsule, endospores and 
flagella. G.vaginalis usually measures 0.4 X 1.0 to 1.5 microns.  They stain 
very unevenly making look partially gram positive and partially gram 
negative. They are facultative anaerobes and only organism in their 
species.  
 
ULTRASTRUCTURE 
 The cell wall of G.vaginalis is relatively thin. It has low 
peptidoglycan content constituting about 20 – 23 % of total cell wall 
content. Though the typical organization of the cell wall content shows that 
it is a gram positive organism, the thinness and low peptidoglycan content 
were suggestive of gram negativity. But cell wall does not contain classical 
lipopolysaccharide( 2-keto-3-deoxy-D-manno-2-octanoic acid) and it also 
has low level of endotoxin which are characteristic of gram negative 
organism. This explains the gram variability of G.vaginalis.  
 
Exopolysaccharide is a layer which lies outside the cell wall and it 
helps in adhesion of bacteria to vaginal epithelial cells. Pilli of diameter 
ranging from 3 – 7.5 nm radiates from the surface of G.vaginalis.   
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During division they exhibit typical picket fence arrangement which 
occurs as result of snapping. They produce Volutuin or metaphosphate 
granules. When these granules are stained with alkaline methylene blue 
they stain gram positive or metachromatic. These features are typical of 
coryneform bacteria. 
 
         The medium used for G.vaginalis is HBT – human-blood-bilayer-
tween. This layer was developed by Totten. It has a bottom layer which 
consists of Columbia colistin – nalidixic acid agar with 1% protease 
peptone, amphotericin B, and Tween 80 and top layer consist of the above 
combination along with 5% human blood. Tween 80 enhances hemolysis 
and also the bacterial growth. As G.vaginalis causes beta hemolysis, this 
medium helps to differentiate it from non – hemolytic colonies. 
 
The characteristic features of Gardnerella vaginalis are 
• Hemolysis of human blood but not sheep blood 
• Presence of alpha glucosidase activity 
• Absence of beta glucosidase activity 
• Hydrolysis of starch and hippurate activity 
• Mannitol non fermentation.(6) 
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MOBILUNCUS SPECIES 
 
Kingdom Bacteria 
Phylum Actinobacteria 
Class Actinobacteia 
Subclass Actinobacteridae 
Order Actinomycetales 
Suborder Actinomycineae 
Family Actinomycetaceae 
Genus Mobiluncus 
          
 They are gram negative/variable, anaerobic, curved rods which is 
isolated from the female patient with Bacterial vaginosis. It is most 
commonly associated with Gardnerella vaginalis. There are two subspecies 
of Mobiluncus : M.curtisii, M.mulieris.  
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The two subspecies differ in following characters: 
S.no Features M.curtisii M.mulieris 
1 Size 1 – 2 microns (short forms) 
3 – 4 microns(long 
forms) 
2 Gram stain Gram variable Gram negative 
3 Shape Comma shaped curved 
4 Metronidazole sensitivity Resistant Sensitive 
5 Beta galactosidase 
acitivity Positive Negative 
6 Arginine hydrolysis Positive Negative 
7 Hippurate hydrolysis Positive Negative 
 
 Both the species has multiple flagella and lacks outer membrane. 
The organisms are isolated from male urethra and extra genital sites like 
breast in breast abscess.(7) 
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Fig.b-Mobilincus spp 
 
MYCOPLASMA 
Mycoplasma are gram negative intracellular bacteria that lacks cell 
wall. M.genitalium and M.hominis are the two species responsible for 
Bacterial vaginosis. 
 
HISTORY 
Kronig in 1895 reported a motile rod that he thought normally 
occurred in the female genital tract of pregnant women. This motile rod 
was later described as Mobiluncus species by Hjelm in1981, Spiegel in 
1984 and Durieux in 1980. 
 
Curtis in 1913 isolated the same curved anaerobic bacterium from a 
lady who suffered with puerperal fever. Later in 1914 Curtis stated that the 
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normally vaginal flora has mainly Lactobacilli and if anaerobic rods are 
present, they lead to vaginal discharge.  
 
         Schroder in 1921 also described about the shift in vaginal flora. He 
classified the vaginal discharge into three types: 
 
1. Predominantly by Lactobacilli  
2. Contains mixture of Lactobacilli and other bacteria 
3. Absent lactobacilli. 
 
Since the specific agent that caused this vaginitis could not be 
identified, they later used the term Non specific vaginitis.  
 
In women with non specific vaginitis Gardner and Duke in 1955 
isolated Haemophilus vaginalis and named it as Haemophilus vaginalis 
vaginitis. In 1961 LaPage showed that haemophilus lacks factor X and 
factor V which were characteristic features of haemophilus species. 
Greenwood in 1980 named this organism as Gardnerella vaginalis. The 
term bacterial vaginosis was coined in 1984, at the second international 
meeting on this syndrome.(10)(11)(12) 
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EPIDEMIOLOGY  
 Bacterial vaginosis is a dysbiosis(13) and it is one of the most 
common cause for abnormal vaginal discharge in women of reproductive 
age.  
 
 The prevalence of Bacterial vaginosis varies with the type of 
diagnostic methods used. BV occurs in about 30% of population and is a 
remarkably prevalent disease. In National Health and Nutrition 
Examination Survey, conducted between 2001-2004 the prevalence was 
about 3.13 times high in African Americans when compared to whites. 
Interestingly 20% of women who doesn’t have BV during their first visit 
were found to be positive for BV next time. History of an STI and multiple 
sexual partners favored developing BV. Prevalence of BV was high among 
homosexual females. Douching increases the incidence of BV. Condom 
use has protective effect in transmission of BV. Increased risk of BV was 
seen among smokers which may be due to suppression of growth of 
hydrogen peroxide–producing lactobacilli. Though the epidemiological 
study of BV suggests that it is sexually transmissible agent, it cannot 
explain the high prevalence of BV among sexually inactive women. Even 
these studies failed to demonstrate a decrease in recurrence of BV among 
the females whose partners were treated. BV is less frequent among 
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African American women. It is not clear how oral contraceptive pills have 
protective effect on BV.(14) 
 
 In a study conducted among 100 adolescent females in Brazil, the 
prevalence of  Bacterial vaginosis was 20%, vulvovaginal Candidiasis was 
22%, and one female had Trichomoniasis. They observed the coexistence 
of Candida with T. vaginalis and C. albicans with bacterial vaginosis in 
two patients. Patients with Bacterial vaginosis had multiple sexual partners 
when compared to those without disease.(13) 
 
A study conducted at Sri Ramachandra Medical College, Chennai by 
Nugent’s scoring method among symptomatic ante-natal women showed 
prevalence of Bacterial vaginosis 38.5% and intermediate score was seen 
in 20%. The patients with Nugent’s score can go for frank BV later on. 
Only 32.2% of patients showed clue cell positivity. The coinfection of 
Chlamydia trachomatis with bacterial vaginosis was seen in 7 (12.7%) 
cases.(15) 
 
 Vaginal discharge was the most common clinical feature seen in 
45% of cases with Bacterial vaginosis and 68.2% of cases with Candida 
infection. About 10% of cases with BV have genital itching, 
dysmenorrhea, and genital lesions.  
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           About 84% of women who is found to BV positive don’t have any 
symptoms. This statistics shows the volume of subclinical cases. BV 
infection can be seen even in nonsexual women. In one study conducted 
among women who have not indulged in vaginal, anal, oral sex, Bacterial 
vaginosis was seen in 18.8% of them. The incidence of BV was high 
among African Americans - 51%, Mexican Americans – 32%, white 
women – 23%.(16)(17) 
 
Following are the risk factors for BV 
• Multiple male sex partners. 
• New sexual partners. 
• Irregular condom usage. 
• Uncircumscised male sexual partners. 
• Use of alcohol, tobacco and illegal drugs. 
• Smoking. 
• Past history of pregnancy. 
• < 13 years of education. 
• Poor genital hygiene.(13) (18) 
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PATHOGENESIS AND BIOCHEMICAL CHANGES 
 The pathogenic microbes increased in Bacterial vaginosis produce 
virulence factors and antimicrobial substances which includes 
lipopolysaccharidases, sialidases, mucinases, etc. Cytolysin (Gvh) is an 
important virulence factor of G. vaginalis, which elicits specific IgA 
response. Mucinases cleaves the mucin thereby helps in adherence of 
bacteria. 
 
Sialidases are enzymatic agents. Sialidase cleaves the sialic acid 
resiudes of immunoglobulins IgA & IgM thereby impairing the mucosal 
defence mechanism of these immunoglobulins. This makes them more 
susceptible to protease degradation. Very high sialidase activity is seen in 
50% of Bacterial vaginosis patients.  Prevotella and Bacteroides species 
present in BV are the main organisms producing sialidase. . The 
persistence or recurrence of sialidase activity after antibiotic treatment 
increases the risk of  
 
• Premature rupture of membrane 
• Low birth weight 
• Preterm birth.(19) 
 
 The anaerobic bacteria produce enzymes such as aminopeptidases 
and decarboxylases. The aminopeptidases degrade proteins into 
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aminoacids and these aminoacids are converted into amines by 
decarboxylases. The amines produced are putrescine, cadaverine, and 
trimethylamine. Trimethylamine is     mainly produced by Mobiluncus 
species. These amines are responsible for raise in vaginal pH and 
characteristic “fishy odour” of the vaginal discharge.  
 
These amines along with the organic acids like acetic acid and 
succinic acid produced by anaerobic organisms causes exfoliation of 
vaginal epithelial cells. This in turn results in non inflammatory exudates. 
The alkaline pH makes the organisms to adhere to vaginal epithelial cells 
to form clue cell. 
 
CLINICAL FEATURES 
 Bacterial vaginosis is the most important cause of vaginal discharge 
in reproductive-aged women where normal vaginal flora is replaced by 
pathogenic micro organisms. In most of the women it remains 
asymptomatic. 10 to 66% of women with Bacterial vaginosis are 
symptomatic.(20) 
 
The patient with BV presents with following symptoms 
1. Abnormal excessive vaginal secretion 
2. Vulval itching but usually non pruritic 
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3. Characteristic rotting fishy odour, which increases after sexual 
intercourse and during menstruation 
4. Vulval soreness or irritation 
5. Vulval burning sensation 
6. Dysuria  
7. Abdominal pain 
8. Pain during coitus 
 
 The vaginal discharge is characteristically milky or homogenous, 
low in viscosity, whitish or grayish, free of grossly visible clumps of 
epithelial cells and sometimes adherent to vaginal wall. Vaginal pH is 
alkaline, which is more than 4.5. The characteristic fishy odour can be 
observed by smelling the vaginal secretion while withdrawing the 
speculum or by alkalizing the vaginal fluid.   
 
COMPLICATIONS 
Morbidities and complications associated with bacterial vaginosis are 
 
• Plasma cell endometritis  
Due to uterine contraction, the vaginal fluid containing pathogenic 
micro organisms and other bacterial toxins are transported into the 
uterus during the period of ovulation and labour. 
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• Vaginal cuff cellulitis 
          It is post operative pelvic infection following hysterectomy. 
 
• Pelvic inflammatory disease 
Patients with Bacterial vaginosis, who had undergone invasive 
procedures like IUCD insertion & procedures like dilatation and 
curettage develops post procedure pelvic inflammatory disease.(21)  
 
• Premature rupture of membrane 
The mixture of enzymes produced by altered microbial flora causes 
breaking down of mucus which helps in invasion of membrane and 
weakens the chorio-amniotic membrane which leads to premature 
rupture of membrane.(22) 
 
• Pre term delivery 
• Lowbirth weight 
• Intra amniotic fluid infection 
• Chorio amnionitis 
• Post partum endometritis after caesarean section and vaginal 
delivery 
• Post abortion pelvic infection 
• Increased risk of HIV transmission 
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DIAGNOSIS 
Diagnosis of Bacterial vaginosis can be done by both clinical criteria 
and laboratory based tests. Laboratory methods include Gram stain of the 
vaginal fluid, biochemical tests to detect metabolic products produced by 
pathogenic bacteria, molecular methods, culture of G. vaginalis. 
 
SPECIMEN COLLECTION 
 During the comprehensive pelvic examination by a speculum 
material for diagnosis of BV is collected. Nature of the discharge is 
assessed and using a sterile swab the specimen is collected from posterior 
fornix and lateral wall of vagina. 
 
         The specimen can be used for bedside clinical testing or laboratory 
based testing. The swab can also be smeared over the glass slide and dried 
and transported. The specimen is usually transported at room temperature 
or at 4°C.  
 
CLINICAL CRITERIA 
 In 1983, Amsel’s et al proposed clinically based diagnostic criteria 
and it is the most widely used method for diagnosis of Bacterial Vaginosis. 
Bacterial Vaginosis could be established by the presence of three of the 
following four features: 
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• Vaginal pH > 4.5 
• Excessive homogenous, thin, gray, uniformly adherent vaginal 
discharge 
• Positive amine test 
• Clue cell constituting 20% or more of total vaginal epithelial cells 
 
Vaginal pH 
 Vaginal pH is determined by using short range pH strips of range 
4.0 to 6.5. The pH strips can be directly touched on the vaginal wall or a 
swab is touched over the vaginal wall and placed over the pH strips. 
Vaginal pH will be more than 4.5 in BV which indicates infection. The pH 
is elevated in 90% of cases of BV. 
 
Vaginal discharge 
 It is thin, gray, homogenous, which smoothly coats the vaginal wall. 
 
Amine test or whiff test  
 This test is done by 2 methods. 10% KOH is placed over vaginal 
speculum after it is withdrawn from the vagina or the vaginal swab is 
smeared over the glass slide and 10% potassium hydroxide is added to the 
smear. Presence of offensive fishy odour confirms the test. The alkaline 
nature of KOH leads to release of volatile amines from the vaginal fluid. 
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The anaerobic bacteria release amines and this is responsible for the 
characteristic offensive odour. This test is positive in 70% of patients with 
Bacterial vaginosis. 
 
Clue cells 
 
Fig.c-Bacterial vaginosis 
 
 Normally the edges of squamous epithelial cells have a sharply 
defined border. Clue cells are the desquamated epithelial cells with large 
number of bacteria, densely attached in clusters to their surfaces so that 
their cell borders are no longer clearly discernible. It has a fuzzy 
cytoplasm. Presence of clue cells is the most important criteria for 
diagnosing Bacterial vaginosis. The vaginal swab is smeared over glass 
slide and a drop of saline is added and cover slip is placed and examined 
under light microscope in 400x magnification to visualize the clue cells.(23) 
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Pseudo clue cells 
 It is seen in cytolytic vaginosis. Other names for cytolytic vaginosis 
are Lactobacillus overgrowth syndrome or Doderline’s cytolysis. It is 
characterized by overgrowth of Lactobacillus leading to lysis of vaginal 
epithelial cells. This condition is often misdiagnosed as vulvovaginal 
Candidiasis which is nonresponsive to antifungal drugs. A study conducted 
by Cerikoglu observed that this condition is seen in 7% of patients with 
vaginal discharge.  
 
 Vulval dysuria, pruritis and dyspareunia are the common symptoms 
seen in this condition. There is cyclical increase in symptoms during luteal 
phase of the menstrual cycle. This condition is also seen in female patients 
having diabetes mellitus. Lactobacilli count increase abnormally which 
lyse the vaginal epithelial cells.  
 
Following criteria are suggestive of cytolytic vaginosis 
• High index of suspicion, 
• Trichomonas, Gardnerella or Candida absent in wet smear. 
• High Lactobacilli count. 
• Decreased leukocytes. 
• Lysis of vaginal epithelial cells. 
• Discharge present. 
• pH is low ranging between 3.5-4.5. 
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LABORATORY BASED TESTS 
GRAM STAIN 
 In 1884, Hans Christian Joachim Gram discovered Gram stain which 
is most widely staining procedure. It is a Gram differential staining 
procedure which differentiates bacteria into gram-positive & gram-
negative bacteria. Ability of microbes to retain the colour of the stain 
which is used for gram staining is tested in this procedure. Gram-
positive bacteria retain the purple colour of primary stain and they are not 
decolorized by alcohol, whereas gram negative bacteria don’t retain the 
primary stain and are decolourised by alcohol. These gram negative 
organisms are counterstained to get a purple colour. 
 
 The amount of peptidoglycan determines whether the cell stains 
positive or negative. Gram-positive bacteria have a thick mesh-like cell 
wall which is made up of peptidoglycan (50-90% of cell wall), which 
stains purple.  Peptidoglycan is mainly a polysaccharide composed of two 
subunits called N-acetyl glucosamine and N-acetyl muramic acid. The 
thick peptidoglycan layer of Gram-positive organisms allows these 
organisms to retain the crystal violet-iodine complex and stains the cells 
as  purple. Gram-negative bacteria have a thinner layer of peptidoglycan 
(10% of the cell wall) and lose the crystal violet-iodine complex during 
31 
 
decolorization with the alcohol rinse, but retain the counter stain Safranin, 
thus appearing reddish or pink. They also have an additional outer 
membrane which contains lipids, which is separated from the cell wall by 
means of periplasmic space. 
 
 A gram variable strain appears as gram positive in the early 
exponential growth stage and becomes gram negative in old cultures. This 
is because peptidoglycan content of the cell wall decreases with maturity 
of these organisms. 
 
There are four steps in the Gram Stain procedure. They are: 
1) Application of the primary stain  
 Crystal Violet (CV) is a primary stain used in gram staining. It is 
applied to a heat-fixed bacterial smear. In aqueous solution this crystal 
violet dissociates into two ions: CV+ and  Cl –. The cell wall and 
membrane of both gram positive and gram negative bacteria is peneterated 
by these two ions. The bacterial components which are usually negatively 
charged interact with CV+ ions which lead to purple staining of bacterial 
cells. 
 
2)  Addition of Iodine 
Gram’s Iodine (I – or I3 –) is used as a mordant and trapping agent. 
Mordant increases the cell wall affinity for the primary stain. Iodine forms 
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an insoluble complex with the primary stain and this complex is trapped in 
the cell wall which becomes dark purple. Both gram positive and gram 
negative organisms turn into purple colour at this stage.  
 
3) Decolorization with ethyl alcohol 
         On adding acetone or alcohol the outer lipid membrane of gram 
negative bacteria gets dissolved there by exposing the peptidoglycan layer 
which increases porosity of the cell wall. The crystal violet iodine complex 
(CV-I) gets washed away making Gram negative bacteria colorless.  
 
 In contrast the alcohol causes dehydration of the cell wall of gram 
positive bacteria which makes the pores in the cell wall to shrink. Further 
the CV-I complex is tightly bound to the multi-layered and highly cross-
linked cell wall of Gram positive bacteria and stains them purple. 
 
 The decolorization should not be for too longer or shorter period. 
Over-decolorization washes away the CV-I complex from Gram positive 
cell wall making them looks like Gram negative. Whereas under-
decolorization does remove crystal violet iodine complex which makes 
Gram negative bacteria to look like a Gram positive. 
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4)  Counterstaining with Safranin  
 Safranin is a positively charged substance which counterstains the 
decolourized Gram negative bacteria making them stain pink. This pink 
colour also adheres to Gram positive bacteria but the primary purple colour 
given by crystal violet masks the pink colour. Sometimes basic fuschin is 
also used for counterstaining. 
 
 
     Fig d. Colour changes that occur at each step in the staining process 
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SPIEGEL’S CRITERIA 
The scoring for Bacterial vaginosis by Gram stain was earlier 
proposed by Spiegel et al which were later modified by Nugent and it is 
most now widely accepted. Bacterial vaginosis is said to be present if less 
than five Lactobacilli per oil immersion field and five or more G.vaginalis 
along with five or more other morphotypes(curved gram variable rods, 
small gram negative rods, gram positive cocci) present per oil immersion 
field. Gram stain was considered to be normal when more than five 
Lactobacilli per oil immersion field present and less than five other 
morphotypes present according to Spiegel’s criteria. 
NUGENT’S CRITERIA 
For this test swab is obtained from the lateral vaginal wall and it is 
smeared over the glass slide. The smear is heat fixed and gram staining is 
done. Under oil immersion microscope using 1000x magnification the 
slide is examined to determine the overall predominance of vaginal 
bacterial flora. The following morphotypes are noted in this Nugent’s 
criteria: large gram positive rods which are Lactobacillus, small gram 
variable rods which are Gardnerella vaginalis, small gram negative rods 
which are Bacteroids and curved gram variable rods which are Mobiluncus 
species.  
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Nugent’s score is interpreted as follows: 
Bacterial morphological 
type 
Score 
None 1+ 2+ 3+ 4+ 
Lactobacilli type 
(large, gram positive 
rods) 
4 3 2 1 0 
Gardnerella / Prevotella 
species 
(small gram negative or 
variable rods) 
0 1 2 3 4 
Mobiluncus species 
(curved gram negative or 
variable rods) 
0 1+ or 2+ 
3+ or  
4+   
 
 
INTERPRETATION (23) 
< 1 / oil immersion field -         1+ 
1-5 / oil immersion field-          2+ 
6-30/ oil immersion field-         3+ 
>30/ oil immersion field-          4+ 
 
SCORE  
0-3   - Normal 
4-6   - Intermediate 
7-10- Bacterial vaginosis  
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HAY/ISON CRITERIA 
• Grade1(Normal): Lactobacilli morphotypes predominant 
• Grade2(Intermediate): Mixed flora with Lactobacilli but other 
Morphotypes like Gardenerella and Mobiluncus also present. 
• Grade3 (Bacterial vaginosis): few or absent Lactobacilli with 
predominance of G.vaginalis and Mobiluncus.  
 
CULTURE 
 Although culture is the gold standard method for diagnosis of 
bacterial infections, it is not the gold standard method for diagnosis of BV 
as it is a polymicrobial infection and the organisms causing BV cannot be 
isolated easily. 
 
OTHER METHODS 
 
Polymerase chain reaction 
Oligonucleotide hybridization (16S rRNA sequencing) for 
identification of both genus and species of Lactobacillus has been 
developed. 
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Sodium docedyl sulphate polyacrylamide gel electrophoresis(SDS 
PAGE)  
 SDS PAGE gives information about whole cell protein patterns 
which will useful in identifying Lactobacillus species. 
 
Proline aminopeptidase test 
 Proline aminopeptidase is an enzyme produced by Mobiluncus and 
other BV associated organisms. Proline naphthylamide gets coverted to 
naphthylamine by the enzymes in vaginal fluid. This is the rapid diagnostic 
method for the detection of Bacterial vaginosis. 
 
Gas liquid chromatography 
 Gas liquid chromatography is used to identify the organic acid 
produced by various organisms. Lactobacilli produce lactic acid. 
G.vaginalis produces acetic acid. Mobiluncus, Porphyromonas, Prevotella 
and Bacteriods produce succinic acid. In BV, the vaginal fluid should have 
increased quantity of succinic acid and decreased lactic acid. The ratio of 
succinate to lactate should be more than 0.4 for diagnosis of BV.  
 
Other laboratory tests done for BV are, Fem Exam pH and amine 
test card, Affirm vp III microbial identification test using nucleic acid 
probe, liquid preparation papanicolaou smear etc. 
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DIFFERENTIAL DIAGNOSIS OF VAGINITIDES(24) (25) (26) 
 
Clinical 
elements 
Bacterial 
vaginosis Trichomoniasis 
Vaginal 
Candidiasis 
Symptoms 
Vaginal odour + +/- - 
Vaginal 
discharge 
Thin, gray, 
homogenous Green yellow 
White, curd 
like 
Signs 
Vulvar irritation +/- + + 
Dyspareunia - + - 
Vulvar erythema - +/- +/- 
Bubbles in 
vaginal fluid + +/- - 
Strawberry 
cervix - +/- - 
Microscopy 
(saline wet 
mount & 
KOH test) 
Clue cells + - - 
Motile protozoa - + - 
Pseudohyphae - - + 
Whiff test + +/- - 
pH >4.5 >4.5 <4.5 
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ASSOCIATION OF BACTERIAL VAGINOSIS 
BV & HIV 
 Lactobacillus has a microbicidal property which is protective against 
HIV infection. Lactobacillus acts against HIV in following ways 
 
• Produce peroxidase-halide system which is cidal to HIV 
• Lactic acid produced by lactobacilli creates an acidic environment 
which inactivates HIV. 
• The acidic environment also results in decreased activation of T-
lymphocytes, thereby decreasing its susceptibility to HIV 
infection.(27) 
• Stimulates the local immune system 
• Competitively binds to vaginal epithelial cells thereby displacing the 
other infective micro organism.(28) 
• Production of hydrogen peroxide which is toxic to HIV virus.(29) 
 
 The organisms causing Bacterial vaginosis increase the 
susceptibility of the patient to HIV infection. Polymorphonuclear 
leukocyte function is inhibited by succinate which is produced by Gram 
negative rods causing BV. Sialidases produced by BV producing 
organisms stimulate lymphocytes directly which increases the 
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susceptibility to HIV infection. Sialidases also modify leukocyte oxidative 
bursts and produce mucinases which affects the protective mucosal barrier 
of genital epithelium. 
 
 U.urealyticum, is the most common organism associated with BV. It 
secretes IgA proteases, thereby altering the mucosal immune system.(27) 
 
 The vaginal pH is pH more alkaline if there is BV. In the alkaline 
environment CD4 cells will be activated which are the target cells for HIV 
infection. TNF alpha and IL-1b levels from the cervical secretions of BV 
patients are increased which increases the replication of HIV virus. 
Prevotella bivia, Peptostreptococcus asaccharolyticus which are associated 
with Bacterial vaginosis causes increased expression of HIV virus in 
monocytoid cells and T cells. STIs are very important biological risk factor 
for acquiring and transmission of HIV. In a study conducted by Meyer et 
all in south African population he stated that nearly 1/3rd of HIV new cases 
can be prevented if all the bacterial vaginosis cases can be cured. With the 
available treatment modalities only 70 – 80% cure rate can be achieved 
and there is also a high incidence of recurrence of BV.(28) 
 
 There is a conflict regarding stating BV as an STI. Usually in STIs 
there will be breakage of skin/mucosal defense mechanisms, bleeding or 
inflammatory exudates which leads to the increased transmission of HIV. 
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No such changes are noted in the vagina of BV patients. G.vaginalis 
produces a heat stable protein which increases the production of HIV by 77 
fold from the HIV infected cells. Mycoplasma hominis acts as a potent 
inducer of HIV virus expression.(29) 
 
TREATMENT 
 There are several anti-microbial agents which are used to treat 
symptomatic BV. The guidelines for treatment of Bacterial vaginosis  are 
given by world health organization(WHO), centre for disease 
control(CDC), national AIDS control organization. 
 
WHO GUIDELINES(34) 
WHO guidelines for treatment of BV were given in 2003. 
 
Recommended regimen 
 Metronidazole tablet 400 or 500 mg orally, twice daily for 7 days. 
 
Alternate regimen 
 Metronidazole, 2 g orally as single dose or tablet  
 Clindamycin 2% vaginal cream, 5 g intravaginally, at bed time for 7 
days 
 Metronidazole 0.75% gel, 5g intravaginally, twice daily for 5 days  
 Clindamycin 300mg orally, twice daily for 7 days. 
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CDC GUIDELINES(35) 
Centre for disease control has given the treatment regimen in 2006.  
 
Recommended regimens 
 Metronidazole 500 mg orally twice a day for 7 days 
 Metronidazole gel, 0.75% one full applicator(5g) intravaginally, 
once a day for 5 days  
 Clindamycin cream 2% one full applicator (5g) intravaginally at 
bedtime for 7 days. 
Alternate regimens  
 Clindamycin 300 mg orally twice a day for 7 days  
 Clindamycin ovules 100 mg intravaginally once at bedtime for 3 
days 
 
NACO GUIDELINES(36) 
 NACO has set guidelines for treatment of Bacterial vaginosis in 
2004. 
 
Recommended regimens  
 Metronidazole 400 mg orally twice daily for 7 days  
 Metronidazole 2g orally as a single dose  
 Tinidazole 2 gm orally as a single dose.  
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 However in symptomatic women in the first trimester and those 
intolerant to Metronidazole or Tinidazole, Imidazole pessaries cream 
may be given for 7 days. 
 
METRONIDAZOLE 
Metronidazole is an antimicrobial drug belonging to nitroimidazole 
group. It is mainly used in the treatment of protozoal infections like 
trichomoniasis and anaerobic infections. Metronidazole is widely used 
since 1980 for treatment of BV and it has produced good clinical results.  
 
ROUTES OF ADMINISTRATION 
This drug can be administered in various routes for BV like oral or 
vaginal and the effectiveness of each regimen have been extensively 
studied. A study was conducted to compare the efficacy of 0.75% 
metronidazole vaginal gel 5 g, twice daily for 5 days vs oral Metronidazole 
500 mg twice daily for 7 days. The efficacy of both the regimen was 
similar and the vaginal regimen doesn’t have any gastrointestinal side 
effects.  
There are various oral regimens of metronidazole used in the 
treatment of BV. They are 
 Single dose of 2 gm Metronidazole 
 2 gm single dose given daily for 2 consecutive days 
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 400 mg BD/TDS given for 5 days 
 500 mg BD dose for 7 days. 
 
The cure rates was high for the 7 days regimen, which is around 82%. 
 
ADVERSE EFFECTS 
 Gastrointestinal side effects like nausea, vomiting and metallic taste 
in mouth are commonly seen with oral regimen. Other common side effect 
is Candidiasis. 
 
OTHER TREATMENTS  
PROBIOTICS 
 Probiotic capsules can be administered intravaginally or orally for 
patients suffering from BV. The cure rate was around 85%. The organisms 
that can be used as probiotics are L.fermentum, L. rhamnosus, L. reuteri 
and L. crispatus. 
 
Prebiotics are the substances which supply nutrients for the growth 
of lactobacillus. Oligosaccharide is a prebiotic which selectively improves 
the growth of lactobacillus and it can be used in BV. 
 
           Vaginal douches with thymol, glycerol monolaurate have antiseptic 
properties and can be used in the treatment of BV. 
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Novel vaginal delivery system containing Metronidazole called 
Hydrogel which swells up in vagina. 
 
         Nifuratel is a new antiprotozoal and antifungal agent belonging to 
Furane derivative is under trial.(37) 
 
RECURRENCE 
Recurrent Bacterial vaginosis is defined as four or more appearance 
of infection in one year. Mostly recurrent BV is due to reactivation. There 
is no optimal treatment option for BV till now. Various treatment options 
for recurrent BV are 
 
• Re-treatment with metronidazole or clindamycin 
• Local treatment with clotrimazole 
• Supplementation of H2O2 
• Lyophilized L.acidophillus vaccination 
• Insertion of intravaginal lactobacillus capsules 
• Probiotics 
• Removal of IUCD 
  
  
 
 
Aims & Objectives 
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AIMS & OBJECTIVES 
 
1. To compare the efficacy of Amsel’s criteria and Nugent’s score in 
diagnosing Bacterial vaginosis.  
 
2. To study the prevalence of Bacterial vaginosis in patients attending 
STD clinic. 
 
3.  To study the co-existence of Bacterial vaginosis with other STIs. 
  
  
 
 
Materials & Methods 
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MATERIALS & METHODS 
 
STUDY DESIGN 
 Prospective Observational study 
 
STUDY GROUP 
100 female patients attending the STI Out Patient Department, 
Institute of Venereology, Madras Medical College/RGGGH, Chennai are 
selected randomly. Both asymptomatic and symptomatic patients are taken 
for the study. Patients with complaints of vaginal discharge, vulval itching, 
lower abdominal pain, dyspareunia are taken as symptomatic patients. 
 
The Institute ethics committee clearance was obtained and informed 
consent was taken from the women included in study group. 
 
INCLUSION CRITERIA   
1. Patients aged >18 yrs < 50 yrs. 
2. Female patients attending STD OP with complaints of vaginal 
discharge, dyspareunia, dysuria and vulval itching. 
3. Patients with nil complaints – Asymptomatic. 
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EXCLUSION CRITERIA 
1. Patient aged <18 yrs and >50 yrs. 
2. Pregnant, lactating & menstruating women. 
3. Patient who are not willing to participate in the study. 
4. Those patients who had used antibiotics and topical vaginal creams     
within 7 days prior to date of examination. 
 
HISTORY 
           A detailed and thorough history was obtained pertaining to the 
following parameters: 
 
• Age 
• Occupation 
• Socioeconomic status 
• Marital and obstetric history 
• Sexual history 
• Contraceptive use 
• Past, Personal, Treatment history 
• History related to sexually transmitted infections as per the proforma 
enclosed 
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GENITAL EXAMINATION 
 A thorough external genital examination was done.Any growth, 
swelling, discharge was noted. Using clean and unlubricated Cusco’s 
bivalve speculum, a thorough pelvic examination was done and any 
abnormalities in the vagina, cervix were noted. The amount, odour, colour 
and consistency of vaginal discharge were noted. Bimanual examination 
was done to note any adnexal tenderness. 
 
SAMPLE COLLECTION 
• The vaginal discharge was collected from the posterior fornix of the 
vagina using a sterile cotton swab. Four such swabs were used to 
collect the specimen from each patient: 
1. First swab was used for pH determination. 
2. Second swab was immediately subjected for wet mount 
examination using normal saline. The sample was streaked over a 
clean glass slide and a drop of saline was placed over it  and 
examined under 100X and 400X magnifications to observe for 
the presence of clue cells and motile Trichomonads. 
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3. Third swab was used for whiff test and KOH mount. After 
streaking the sample over a clean glass slide, a drop of 10% 
potassium hydroxide was added and whiffed for amine or fishy 
odour and the same was subjected to microscopy under 100X and 
400X magnifications to note the presence of budding yeast cells 
and pseudohyphae. 
4. Fourth swab was subjected to Gram stain. The sample was 
streaked over a clean sterile glass slide and Gram stain was done 
to note the presence of clue cells and pseudohyphae with spores. 
• A cervical swab was taken for gonococcal culture.  
• Blood samples were collected for VDRL and HIV antibody testing. 
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A flowchart showing the methodology followed in our study 
 
 
Female Patient attending STD clinic 
 
 
Genital examination 
 
 
Nature of discharge noted 
(Amsel’s criteria –1) 
 
 
Sample collected 
 
 
 
 
Vaginal discharge Cervical discharge 
 
 
 
 
Blood 
 Gonococci Culture HIV Test 
VDRL 
 
 
 
pH noted 
(Amsel’s 
criteria-2) 
Amine Test 
(Amsel’s 
criteria-3) 
Wet mount in 
Normal Saline 
 
 
 
 
Wet mount in 
KOH 
 
Gramstain 
  1. Trichomonas 
2. Clue cells 
(Amsel’s 
criteria-4) 
Candida 1. Candida 
2. Clue cells 
(Nugent’s 
Score) 
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DIAGNOSIS 
1. Bacterial vaginosis 
 
Amsel’s criteria: 
 Amsel’s criterion was made based on the following criteria: 
 
a. Vaginal discharge  
Excessive homogenous, thin, gray, uniformly adherent vaginal 
discharge. 
 
b. Vaginal pH  
Vaginal secretion from the swab was placed over short range pH 
strips with a pH ranging from 3.5 to 6. The colour change in the pH 
paper was compared to the corresponding colour coding chart and 
pH was noted. pH more than 4.5 was considered as positive. 
 
c. Whiff test  
Vaginal secretion was smeared over the glass slide and add 10% 
potassium hydroxide. When fishy odour was noted, it was 
considered positive. 
 
d. Clue cells 
On wet mount microscopy, if clue cells constituting 20% or more of 
total vaginal epithelial cells were considered as positive. Clue cells 
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are the squamous epithelial cells with large number of bacteria, 
densely attached in clusters to their surfaces so that their cell borders 
are no longer clearly discernible. 
 
Diagnostic criteria 
 Three out of four criteria should be there for labeling it as positive 
for Bacterial vaginosis. 
 
Nugent’s score 
After Gram staining the slide, it was viewed under oil immersion 
field using 1000x magnification to determine the overall predominance of 
vaginal bacterial flora. The following morphotypes are noted in this 
Nugent’s criteria:  
 
• Large gram positive rods which are Lactobacillus 
• Small gram variable rods which are Gardnerella vaginalis 
• Curved gram variable rods which are Mobiluncus species 
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Nugent’s score is interpreted as follows: 
Bacterial morphological 
type 
Score 
None 1+ 2+ 3+ 4+ 
Lactobacilli type 
(large, gram positive rods) 4 3 2 1 0 
Gardnerella / Prevotella 
species 
(small gram negative or 
variable rods) 
0 1 2 3 4 
Mobiluncus species 
(curved gram negative or 
variable rods) 
0 1+ or 2+ 
3+ or  
4+ 
 
 
 
 
 
INTERPRETATION 
< 1 / oil immersion field -         1+ 
1-5 / oil immersion field-          2+ 
6-30/ oil immersion field-         3+ 
>30/ oil immersion field-          4+ 
 
SCORE  
0-3   - Normal 
4-6   - Intermediate 
7-10 - Bacterial vaginosis 
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2. Trichomoniasis: 
 Diagnosis was made based on wet mount microscopy. The slide was 
observed under 400X magnification. 
 
Reading – presence of pear shaped flagellated organisms of size 10-
20µm with characteristic jerky movements.   
 
3. Candidiasis: 
 Diagnosis was made on the presence of budding yeast cells and 
pseudohyphae in Gram stain or KOH mount. 
 
Grams stain method: 
• Vaginal swab was taken from the posterior fornix and smear was 
made, air dried and then heat fixed. 
• Smear was stained with crystal violet solutions for one minute and 
then washed under slow running water. 
• The smear was again stained with Grams iodine solution for one 
minute and washed with slow running water. 
• Next the smear was decolorized with acetone for 20-30 seconds and 
washed immediately in running water. 
• The smear was counterstained with saffranin for 20-30 seconds and 
washed under slow flowing water. 
• Smear was then air dried and viewed under microscope. 
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STATISTICAL ANALYSIS 
The data obtained was tabulated in Microsoft Excel Worksheet and 
computer based analysis was done. Using Chi Square test, the efficacy of 
both Amsel’s criteria & Nugent’s score were compared. The sensitivity 
and specificity of each test and individual criteria is calculated and 
statistical analysis of data done. 
 
SCREENING TEST 
 The ideal screening test must satisfy the criteria of acceptability, 
repeatability, validity, yield, simplicity, rapidity, ease of administration and 
cost. 
 
SENSITIVITY 
 Sensitivity of the test refers to the ability of the test to identify the 
condition correctly. It is otherwise called as “true positives”. It is the 
proportion of the individual known to have disease and tested positive for 
it.  
 
     Number of true positives 
  Sensitivity    =            
   Number of true positives +Number of false negatives 
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 A highly sensitive test is usually low in specificity. A negative result 
in a highly sensitive test rule out the disease whereas positive result in 
highly sensitive test doesn’t confirm the diagnosis. 
 
SPECIFICITY 
 Specificity of the test refers to its ability in correctly ruling out the 
disease. It is otherwise called as “true negatives”. It is the proportion of 
healthy patient not having disease and tested negative for it. 
 
          Number of true negatives 
Specificity =                         
                       Number of true negatives + Number of false positives 
 
 
 A positive result in a highly specific test confirms the diagnosis 
whereas negative result in a highly sensitive test doesn’t rules out the 
disease. 
 
TYPE-1 ERROR 
 Rejecting the null hypothesis when it is actually true is called type-1 
error.  A test with high specificity has a low type-1 error. 
 
TYPE-2 ERROR 
 Accepting the null hypothesis when it is actually false is called type-
2 error. A test with high sensitivity has low type-2 error. 
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POSITIVE PREDICTIVE VALUE 
 Positive predictive value is the probability that subjects with a 
positive screening test truly have the disease. 
 
NEGATIVE PREDICTIVE VALUE 
 Negative predictive value is the probability that subjects with a 
negative screening test truly don't have the disease. 
  
SHORT RANGEpH STRIPS
  
 
 
Observations & Results 
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OBSERVATIONS & RESULTS 
 
TABLE -1: AGE DISTRIBUTION 
AGE GROUP NO OF PATIENTS PERCENTAGE 
20-30 YRS 41 41% 
30-40 YRS 38 38% 
40-50 YRS 21 21% 
TOTAL 100 100% 
 
FIG 1: AGE DISTRIBUTION OF THE STUDY GROUP 
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FIG 2:  SOCIO ECONOMIC STATUS OF STUDY POPULATION
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FIG 3: RESIDENTIAL STATUS OF THE STUDY POPULATION
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FIG 4: MARITAL STATUS OF THE STUDY POPULATION
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TABLE -5: OBSTETRIC HISTORY 
 
 FREQUENCY PERCENTAGE 
NORMAL 
DELIVERY 68 68% 
LSCS 17 17% 
ABORTION 12 12% 
NULLIPARA 1 1% 
NOT APPLICABLE 2 2% 
TOTAL 100 100% 
 
            
 
 
 FIG 5: OBSTETRIC HISTORY OF THE STUDY POPULATION
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FIG 6: CONTRACEPTIVE USE AMONG STUDY POPULATION
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 TABLE -7: PRE/EXTRA MARITAL CONTACT
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FIG 7:  PRE/EXTRA MARITAL CONTACT HISTORY OF THE 
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 TABLE -8: HUSBAND WITH EXTRA MARITAL CONTACT
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FIG 8: HUSBAND WITH EXTRA MARITAL CONTACT 
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FIG 9: SUBSTANCE ABUSE AMONG STUDY POPULATION       
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FIG 10: PAST HISTORY
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FIG 11: TREATMENT HISTORY AMONG STUDY POPULATION
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TABLE -12: SYMPTOMS IN STUDY POPULATION 
 FREQUENCY PERCENTAGE 
VAGINAL 
DISCHARGE 25 25% 
ITCHING 6 6% 
LOWER ABD PAIN 2 2% 
GROWTH/SWELLING 2 2% 
FOUL SMELLING 
DISCHARGE 6 6% 
DISCHARGE 
+ITCHING 5 5% 
ITCHING+LAP 5 5% 
NIL 49 49% 
TOTAL 100 100% 
 
 
 FIG 12: VARIOUS SYMPTOMS AMONG STUDY POPULATION
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 DEMOGRAPHIC CHARACTERS IN NUGENT’S POSITIVE PATIENTS
TABLE-13: AGE DISTRIBUTION IN NUGENT’S POSITIVE 
AGE(IN YEARS) 
20-30 
31-40 
>40 
TOTAL 
 
FIG 13: AGE DISTRIBUTION AMONG NUGENT’S POSITIVE 
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 TABLE -14:  SOCIO ECONOMIC STATUS OF NUGENT’S 
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FIG 14: SOCIO ECONOMIC STATUS OF NUGENT’S POSITIVE 
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 TABLE -15: MARITAL STATUS OF NUGENT’S 
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FIG 15: MARITAL STATUS OF NUGENT’S POSITIVE PATIENTS
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MARITAL STATUS
 HIGH RISK AND BEHAVIOURAL CHARACTERISTICS OF 
NUGENT’S POSITIVE PATIENTS
TABLE -16: CONTRACEPTIVE USE AMONG NUGENT’S 
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FIG 16: CONTRACEPTIVE USE AMONG NUGENT’S 
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TABLE -17: PRE/EXTRA MARITAL CONTACT IN NUGENT’S 
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FIG 17: PRE/EXTRA MARITAL CONTACT IN NUGENT’S 
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 TABLE -18: HUSBAND WITH EXTRA MARITAL CONTACT IN 
NUGENT’S POSITIVE PATIENTS
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FIG 18: HUSBAND WITH EXTRA MARITAL CONTACT IN 
NUGENT’S  POSITIVE PATIENTS
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 TABLE -19: SUBSTANCE ABUSE IN NUGENT’S 
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FIG 19: SUBSTANCE ABUSE IN NUGENT’S 
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 TABLE -20: SIGNIFICANT PAST HISTORY AMONG 
NUGENT’S
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FIG 20: SIGNIFICANT PAST HISTORY AMONG 
NUGENT’S POSITIVE PATIENTS
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TABLE -21: VARIOUS SYMPTOMS IN NUGENT’S POSITIVE 
PATIENTS 
 FREQUENCY PERCENTAGE 
VAGINAL DISCHARGE 16 31.4% 
ITCHING 4 7.8% 
LOWER ABD PAIN 1 1.9% 
GROWTH/SWELLING 1 1.9% 
FOUL SMELLING 
DISCHARGE 
3 5.9% 
DISCHARGE+ITCHING 2 3.9% 
ITCHING+LAP 4 7.8% 
NIL 20 20% 
TOTAL 51 51% 
 
           
 
 
 
 FIG 21: VARIOUS SYMPTOMS IN NUGENT’S 
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TABLE -22: AMSEL’S CRITERIA IN SYMPTOMATIC & 
ASYMPTOMATIC PATIENTS 
 
 
AMSEL’S CRITERIA 
TOTAL 
NEGATIVE POSITIVE 
ASYMPTOMATIC 
16 33 49 
32.7% 67.3% 100.0% 
SYMPTOMATIC 
7 44 51 
13.7% 86.3% 100.0% 
TOTAL 
23 77 100 
23.0% 77.0% 100.0% 
 
 
  
 FIG 22: AMSEL’S CRITERIA IN SYMPTOMATIC & 
ASYMPTOMATIC PATIENTS
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TABLE -23: NUGENT’S SCORE IN SYMPTOMATIC & 
ASYMPTOMATIC PATIENTS 
 
NUGENT’S SCORE 
 
INTERMEDIATE NEGATIVE POSITIVE TOTAL 
ASYMPTOMATIC 
19 10 20 49 
38.8% 20.4% 40.8% 100.0% 
SYMPTOMATIC 
14 6 31 51 
27.5% 11.8% 60.8% 100.0% 
TOTAL 
33 16 51 100 
33.0% 16.0% 51.0% 100.0% 
 
 
 
 FIG 23: NUGENT’S SCORE IN SYMPTO
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TABLE -24:  VAGINAL pH BASED ON AMSEL’S CRITERIA 
 
AMSEL’S CRITERIA 
 
 
 
VAGINAL pH 
 NEGATIVE POSITIVE TOTAL 
4.00 
12 2 14 
85.7% 14.3% 100.0% 
4.50 
3 2 5 
60.0% 40.0% 100.0% 
5.00 
7 37 44 
15.9% 84.1% 100.0% 
5.50 
1 26 27 
3.7% 96.3% 100.0% 
6.00 
0 10 10 
.0% 100.0% 100.0% 
 TOTAL 
23 77 100 
23.0% 77.0% 100.0% 
 
              
  
 FIG 24: VAGINAL pH BASED ON AMSEL’S CRITERIA
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TABLE -25: VAGINAL pH BASED ON NUGENT’S SCORE 
 
 INTERMEDIATE NEGATIVE POSITIVE TOTAL 
Vaginal 
pH 
4.00 
4 6 4 14 
28.6% 42.9% 28.6% 100.0% 
4.50 
1 3 1 5 
20.0% 60.0% 20.0% 100.0% 
5.00 
21 5 18 44 
47.7% 11.4% 40.9% 100.0% 
5.50 
4 1 22 27 
14.8% 3.7% 81.5% 100.0% 
6.00 
3 1 6 10 
30.0% 10.0% 60.0% 100.0% 
 TOTAL 
33 16 51 100 
33.0% 16.0% 51.0% 100.0% 
 
 
 
 
 
 FIG 25: VAGINAL pH BASED ON NUGENT’S SCORE
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TABLE -26: WHIFF TEST BASED ON AMSEL’S CRITERIA 
WHIFF TEST AMSEL’S CRITERIA  
 NEGATIVE POSITIVE TOTAL 
NEGATIVE 
22 42 64 
34.4% 65.6% 100.0% 
POSITIVE 
1 35 36 
2.8% 97.2% 100.0% 
TOTAL 
23 77 100 
23.0% 77.0% 100.0% 
 
                   
 
 
 
                 
 FIG 26: WHIFF TEST BASED ON AMSEL’S CRITERIA
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TABLE -27: WHIFF TEST BASED ON NUGENT’S SCORE 
 
WHIFF TEST 
NUGENT’S SCORE  
INTERMEDIATE NEGATIVE POSITIVE TOTAL 
 
NEGATIVE 
30 13 21 64 
46.9% 20.3% 32.8% 100.0% 
POSITIVE 
3 3 30 36 
8.3% 8.3% 83.3% 100.0% 
 TOTAL 
33 16 51 100 
33.0% 16.0% 51.0% 100.0% 
 
  
 FIG 27: WHIFF TEST BASED ON NUGENT’S SCORE
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TABLE -28: CLUE CELLS BASED ON AMSEL’S CRITERIA 
 
 
AMSEL’S CRITERIA  
NEGATIVE POSITIVE TOTAL 
CLUE CELLS>20% 
9 75 84 
10.7% 89.3% 100.0% 
CLUE CELLS<20% 
14 2 16 
87.5% 12.5% 100.0% 
TOTAL 
23 77 100 
23.0% 77.0% 100.0% 
 
                    
 
 
     
FIG 28: CLUE CELLS BASED ON AMSEL’S CRITERIA
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TABLE -29: CLUE CELLS BASED ON NUGENT’S SCORE 
 
NUGENT’S SCORE 
 INTERMEDIATE NEGATIVE POSITIVE TOTAL 
CLUE CELLS>20% 
24 10 50 84 
28.6% 11.9% 59.5% 100.0% 
CLUE CELLS<20% 
9 6 1 16 
56.25% 37.5% 6.25% 100.0% 
TOTAL 
33 16 51 100 
33.0% 16.0% 51.0% 100.0% 
 
 
 
  
 FIG 29: CLUE CELLS BASED ON NUGENT’S SCORE
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TABLE 30: DISCHARGE CONSISTENCY BASED ON  
AMSEL’S CRITERIA 
 
AMSEL’S CRITERIA 
  NEGATIVE POSITIVE TOTAL 
D
IS
C
H
A
R
G
E 
C
O
N
SI
ST
EN
C
Y
 
FLOCCULAR 
11 2 13 
84.6% 15.4% 100.0% 
MUCOPURULENT 
2 24 26 
7.7% 92.3% 100.0% 
HOMOGENOUS 
8 49 57 
14.0% 86.0% 100.0% 
CURDY 
2 1 3 
66.7% 33.3% 100.0% 
FROTHY 
0 1 1 
.0% 100.0% 100.0% 
 TOTAL 
23 77 100 
23.0% 77.0% 100.0% 
 
 FIG 30: DISCHARGE CONSISTENCY BASED ON 
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TABLE 31: DISCHARGE CONSISTENCY BASED ON  
NUGENT’S SCORE 
  NUGENT’S SCORE 
  INTERMEDIATE NEGATIVE POSITIVE TOTAL 
D
IS
C
H
A
R
G
E 
C
O
N
SI
ST
EN
C
Y
 
FLOCCULAR 
5 5 3 13 
38.5% 38.5% 23.1% 100.0% 
MUCOPURULENT 
5 1 20 26 
19.2% 3.8% 76.9% 100.0% 
HOMOGENOUS 
21 10 26 57 
36.8% 17.5% 45.6% 100.0% 
CURDY 
2 0 1 3 
66.7% .0% 33.3% 100.0% 
FROTHY 
0 0 1 1 
.0% .0% 100.0% 100.0% 
 TOTAL 
33 16 51 100 
33.0% 16.0% 51.0% 100.0% 
    
    
  
  
FIG 31: DISCHARGE CONSISTENCY BASED ON 
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TABLE -32: AMSEL’S CRITERIA & NUGENT’S SCORE 
 
  NUGENT’S_SCORE 
TOTAL 
  INTERMEDIATE NEGATIVE POSITIVE 
AMSEL’S 
CRITERIA 
NEGATIVE 
10 8 5 23 
43.5% 34.8% 21.7% 100.0% 
POSITIVE 
23 8 46 77 
29.9% 10.4% 59.7% 100.0% 
TOTAL 
33 16 51 100 
33.0% 16.0% 51.0% 100.0% 
 
 
 
 
 FIG 32: AMSEL’S CRITERIA & NUGENT’S SCORE
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TABLE -33: COEXISTENCE WITH OTHER STIs IN  
NUGENT’S POSITIVE PATIENTS 
 
 FREQUENCY PERCENTAGE 
CANDIDA 2 3.9% 
TRICHOMONIASIS 2 3.9% 
WART 1 1.9% 
HIV 5 9.8% 
NIL 41 80% 
TOTAL 51 100% 
 
 
 
 FIG33: COEXISTENCE WITH OTHER STIs IN NUGENT’S
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DISCUSSION 
 
 The prevalence of Bacterial vaginosis in females around worldwide, 
varies widely from 4% to 76% depending upon the study population and 
various methods used for the diagnosis. Highest prevalence rates were 
reported among patients attending sexually transmitted diseases clinic. 
 
 In our study, we have included a total of 100 patients attending STD 
clinic. Among these, only 51% of patients were found to be positive for 
BV by Nugent’s score and 77% were found to be positive by Amsel’s 
criteria. Among the Nugent’s positive patients, 60.3% were Symptomatic 
and 40.8% were Asymptomatic. Among the Amsel’s positive patients 
86.3% were Symptomatic and 67.3% were Asymptomatic. 
 
 In a study conducted by Rangari Amit A & Sharma V.K, in 
Muzaffamar Medical College and Hospital, they included 250 female 
patients of reproductive age group attending Gynecology and Obstetric 
OPD/IPD. In this study 145(58%) patients were found to be positive by 
Amsel’s criteria and 79(31.6%) patients were found to be positive by 
Nugent’s score.(5) 
 
 This study shows high positivity by Amsel’s criteria than Nugent’s 
score which is similar to our study. 
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 Another study by Embree Joanne MD at Boston, which included 33 
patients attending STD clinics, the prevalence of  Bacterial vaginosis was 
found to be 64% by Amsel’s criteria.(40) Bacterial vaginosis has a varied 
and high prevalence, depending upon the population surveyed, ranging  
from 4% in developed countries to 61% in the developing countries.(48) 
 
DEMOGRAPHIC CHARACTERS 
AGE 
 The prevalence of Bacterial vaginosis has been shown to be more in 
reproductive age group. This was more evident from our study, where the 
mean age at presentation for patients with Bacterial vaginosis was 20-30 
years. This was comparable to the study conducted in West Bengal by 
Tamonud Moduk who reported a mean age of 28.33±7.90 years.(41)  As per 
study conducted in Hyderabad, 53% of patients with vaginal discharge 
belong to the age group of 21-30 years which indicates that Bacterial 
vaginosis is seen commonly in the early reproductive age group.(51) 
 
RESIDENCE 
 Majority of patients in our study were residing at rural areas 
constituting about 72% and 28% of patients were from urban areas. In a 
study conducted in Delhi, 237 patients were studied and highest prevalence 
(38.6%) was noted in urban slum followed by rural (28.8%).(45) 
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SOCIOECONOMIC STATUS 
 In our study, majority about 31.4% of Bacterial vaginosis patients 
belonged to lower middle socioeconomic status and 19.6% belonged to 
upper middle class. 
 
MARITAL STATUS 
 Although Bacterial vaginosis is not exclusively sexually transmitted 
infection, it is more common in sexually active women of reproductive age 
group which constitutes about 9-50.9% across the world.(42) In our study 
majority of the patients positive for Bacterial vaginosis were 
married(86.3%). The risk of infection being higher in separated women 
(5.9%). This shows that sexually active persons have more chance of 
acquiring infection than sexually inactive persons. 
 
HIGH RISK AND BEHAVIOURAL CHARACTERS 
Contraceptive use 
 The most common method of contraception used in our study 
population was barrier method about 38%, whereas in Bacterial vaginosis 
positive patients it is only 11.7%. No contraception was used in 35% of 
study population and 54.9% of Bacterial vaginosis positive patients. This 
shows that barrier method of contraception is protective against Bacterial 
vaginosis and the risk increases if no contraception is used. 
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 This is in concordance with the study conducted by Harold Moi, in 
which they showed women using barrier contraceptive had significantly 
lower prevalence of Bacterial vaginosis than that of other contraceptive 
used.(43) 
 
Pre/Extramarital contact 
 Pre/Extramarital contact was present in 28% of our patients in study 
group and 31.4% of patients with Bacterial vaginosis. 
 
Husband with extramarital contact 
 About 11% of patients in study group gave history of husband 
having Extramarital contact whereas in patients with Bacterial vaginosis, 
13.7% gave positive history which is not statistically significant. 
 
Substance abuse 
 In our study, only two patients with Bacterial vaginosis gave history 
of alcohol abuse and none of the patients gave history of smoking. 
 
Past history of PID/ Infertility/ Recurrence 
 Only 4 women in the study group had history of infertility and 
among these, 3 were found to be positive for Bacterial vaginosis which is 
significant. In a study conducted by J Mania-Pramanik, they reported 
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statistically significant association of Bacterial vaginosis and infertility 
(p=0.0001). (44) 
 
 12 patients in our study group had previous history of PID and out 
of these 9 had Bacterial vaginosis which is significant.  
 
CLINICAL CHARACTERISTICS 
 Bacterial vaginosis is a non specific vaginitis and it is asymptomatic 
in atleast 50% of patients.(50) In our study,  39.2% of Bacterial vaginosis 
positive patients were asymptomatic and 31.4% of patients presented with 
complaints of abnormal vaginal discharge. Abnormal vaginal discharge 
was the most common symptom observed in our study. This was 
comparable to a study done by Kantida Chaijareenont who reported 38% 
of patients with no symptoms and 36.4% with abnormal vaginal discharge 
and pelvic pain. 
 
 In our study, 7.8% of patients gave history of genital itching, 1.9% 
had lower abdominal pain, 5.9% had foul smelling vaginal discharge, and 
3.9% gave history of vaginal discharge with itching. In a study conducted 
by Kantida Chaijareenont, they reported foul smelling discharge in 16.1%, 
vaginal itching in 19.4%,  vaginal irritation in 12.9%, dyspareunia in 
19.8%, pelvic pain in 36.4%.(49) 
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 Among the signs in patients with Bacterial vaginosis, homogenous 
vaginal discharge, mucopurulent discharge, foul smelling discharge were 
significantly associated with Bacterial vaginosis. In our study, moderate 
amount of discharge was noted in 56.9% and profuse discharge was 
noticed in 21.6% of Bacterial vaginosis positive patients. About 51% of 
Bacterial vaginosis positive patients had homogenous vaginal discharge 
and 39.2% had mucopurulent discharge. The characteristic fishy odour was 
observed only in 7.8% of patients with Bacterial vaginosis and none of the 
patients without Bacterial vaginosis had fishy odour. 
 
COMPLICATIONS 
 In a study conducted by Larsson et al, out of 174 patients studied, 14 
of them had pelvic inflammatory disease.(63) When during the first prenatal 
visit if the women was diagnosed as having Bacterial vaginosis, there is 
more chance for early pregnancy loss.(64)  In our study, 12 patients in study 
group gave history of abortion and out of which 8 were positive for 
Bacterial vaginosis. Recurrence of infection was seen in 9.8% of Bacterial 
vaginosis positive patients. 
 
INVESTIGATIONS 
 Amsel’s criteria mainly depend upon clinical signs which cannot be 
quantified and standardized. They depend on the observation of the 
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clinician and it is more prone for inter observer variation thus misdiagnosis 
is very common, which can lead to persistence of infection and adverse 
sequelae. So in this study we have taken Nugent’s score as standard criteria 
for diagnosing Bacterial vaginosis and compared each Amsel’s criteria 
with Nugent’s score. 
 In our study, out of the 100 patients, 51(51%) were diagnosed as 
Bacterial vaginosis positive by Nugent’s score, 33(33%) were diagnosed as 
intermediate BV. By Amsel’s criteria, 77(77%) were diagnosed as 
Bacterial vaginosis among the 100 patients. Both Nugent’s and Amsel’s 
criteria were positive in 46(46%). The sensitivity, specificity, positive 
predictive value, negative predictive value of Amsel’s criteria when 
compared to Nugent’s score were 90%, 50%, 85%, 62% respectively. 
Similarly the sensitivity, specificity, positive predictive value, negative 
predictive value of  Nugent’s score were 85%, 62%, 90%, 50% 
respectively. It shows Amsel’s criterion is more sensitive than Nugent’s 
score and Nugent’s score is more specific than Amsel’s criteria. 
 
 In a study conducted by Jane R et al, the sensitivity of Nugent’s 
score was 92.0% and specificity was 79.5%.(52) Moreover Nugent’s score 
categorize the patients into positive, intermediate and negative for 
Bacterial vaginosis. Intermediate score in Nugent’s is considered as 
transitional phase where the patient can go for frank BV.(53) In our study, 
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23 patients with intermediate score for Nugent’s were positive by Amsel’s 
criteria. 
 
 Comparing each individual components of Amsel’s criteria with 
Nugent’s score, clue cells>20% showed highest sensitivity and whiff test 
showed highest specificity. Homogenous discharge showed lowest 
sensitivity and specificity. This is similar to a study done by Modak et al, 
where clue cells had the maximum sensitivity and amine test or whiff test 
had maximum specificity.(57)  
 
 In our study when compared to Nugent’s score, clue cells>20% had 
sensitivity of 98% and specificity of 31%, whiff test had sensitivity of 59% 
and specificity of 81%, homogenous vaginal discharge had sensitivity of 
51% and specificity of 38%, pH >4.5 showed sensitivity of 90% and 
specificity of 46%. In a study conducted by A.Simoes, most sensitive 
individual criteria were vaginal discharge and pH (97%), and vaginal 
discharge showed lowest specificity (26%). The criterion which had 
highest specificity was the presence of clue cells (86%). The combination 
of two criteria showed sensitivity of 83% to 93%, and specificity of 82% to 
94%. (58)  
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COINFECTION WITH OTHER STIs 
 The most common co infection with Bacterial vaginosis seen in our 
study is HIV constituting about 9.8%. Vulvovaginal candidiasis and 
Trichomoniasis seen in 3.9%, and wart in 1.9% of Bacterial vaginosis 
positive patients is not statistically significant.  
  
  
 
 
Summary 
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SUMMARY 
1) The total prevalence of Bacterial vaginosis in our study by 
• Nugent’s score was 51% 
• Amsel’s criteria was 77% 
•  Both was 46%  
 
2)    Among the Nugent’s positive patients, 60.3% were Symptomatic 
and 40.8% were Asymptomatic. Among the Amsel’s positive 
patients, 86.3% were Symptomatic and 67.3% were Asymptomatic. 
 
3)    The sensitivity and specificity of Amsel’s criteria were 90% and 
50% respectively. The sensitivity and specificity of Nugent’s score 
were 85% and 62% respectively. According to our study Amsel’s 
criteria is more sensitive and Nugent’s score is more specific. 
 
4)    The presence of clue cells >20% had sensitivity of 98% and 
specificity of 31% in diagnosing Bacterial vaginosis. 
 
5)   The sensitivity and specificity of whiff test were 59% and 81% 
respectively. 
 
6)     The pH >4.5 had sensitivity of 90% and specificity of 46%. 
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Thus in our study, clue cells >20% had highest sensitivity and whiff 
test had highest specificity. 
 
5)    Demographic factors in Bacterial vaginosis patients derived from 
our study were, 
 
         a.  Bacterial vaginosis was seen commonly in the reproductive 
age group of 20-30 yrs. 
 
 b.  Majority of Bacterial vaginosis patients were residing in rural 
areas and belong to lower socioeconomic status. 
 
 c.  Most patients were married, about 86.3% and risk of infection 
being higher in separated women (5.9%). 
 
6)    Clinical characteristics of Bacterial vaginosis patients derived from 
our study were, 
 
a.  About 39.4% of Bacterial vaginosis patients were 
asymptomatic and among the symptomatic patients, the most 
common symptom was foul smelling vaginal discharge. Other 
symptoms noted along with vaginal discharge were vulval 
itching and lower abdominal pain.  
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           b.  The characteristic signs noted in patients with Bacterial 
vaginosis were homogenous vaginal discharge and fishy 
odour of the discharge. 
 
 c.  The complications noted in our study were abortion seen in 
10.4% of patients with Bacterial vaginosis and recurrence of 
infection seen in 9.8% of patients with Bacterial vaginosis.  
 
7)   The risk factors associated with Bacterial vaginosis in our study were: 
               a. Low socioeconomic status, rural areas 
               b. Single and separated women  
               c. Women with pre/extramarital contact 
               d. Women whose husbands are promiscuous 
 
8)    The most common coinfection with Bacterial vaginosis in our study 
was HIV. The other infections associated with Bacterial vaginosis in 
our study were Vulvovaginal Candidiasis, Trichomoniasis and 
genital Wart. 
 
  
  
 
 
Conclusion 
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CONCLUSION 
 In our study, the prevalence of Bacterial vaginosis by Nugent’s 
score was 51% and by Amsel’s criteria was 77%. 
 Among the individual components of Amsel’s criteria, whiff test had 
the highest specificity and clue cells >20% had the highest 
sensitivity. 
 Risk factors associated with Bacterial vaginosis were women 
belonging to low socioeconomic status, women who were separated 
from their husbands, women having pre/extramarital contact and 
women whose husbands had extramarital contact. 
 Coinfections with Bacterial vaginosis are HIV, Vulvovaginal 
Candidiasis, Trichomoniasis, and genital Wart. 
 It is concluded from this study that diagnosis of Bacterial vaginosis 
by Nugent’s score is more specific than Amsel’s criteria and 
Amsel’s criteria is more sensitive than Nugent’s score. 
 Amsel’s criteria being a simple and inexpensive method, it can be 
used as a method of diagnosing Bacterial vaginosis where the 
laboratory facilities are inadequate. Nugent’s score requires 
infrastructure facilities with skilled manpower and thus it can be 
used as a diagnostic method in Tertiary Care Centre.  
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Annexures 
  
ABBREVIATIONS USED 
 
AIDS    :  Acquired ImmunoDeficiency Syndrome 
BV    :  Bacterial vaginosis 
CDC    :  Centre for Disease Control 
CFU    :  Colony Forming Unit 
G.vaginalis :        Gardnerella vaginalis 
HIV    :  Human Immunodeficiency Virus 
IUCD    :  IntraUterine Contraceptive Device 
KOH    :  Potassium Hydroxide 
LSCS          :       Lower Segment Caesarean Section 
NACO    :  National AIDS Control Organization 
PID    :  Pelvic Inflammatory Disease 
SD              :        Standard Deviation 
STI    :  Sexually Transmitted Infection 
VDRL    :  Venereal Disease Research Laboratory 
WHO    :  World Health Organisation 
  
 
 
Master Chart &  
Master Chart Coding 
 
 
MASTER CHART 
 
  
   
MASTER CHART CODING 
SOCIOECONOMC STATUS 
UM- UPPER MIDDLE 
LM- LOWER MIDDLE 
UL -UPPER LOWER 
LL- LOWER LOWER 
 
MARITAL STATUS 
M - MARRIED 
UM-UNMARRIED 
W- WIDOW 
S- SEPARATED 
 
PMC/EMC 
P- PRESENT 
A- ABSENT 
 
HUSBAND WITH EMC 
P- PRESENT 
A- ABSENT 
NA- NOT APPLICABLE 
 
OBSTETRIC H/O 
1-NORMAL DELIVERY 
2-LSCS 
3-ABORTION 
4-NULLIPARA 
 
  
CONDOM USE 
1-YES 
2-NO 
 
SYMPTOMATIC /ASYMPTOMATIC 
S-SYMPTOMATIC  
AS-ASYMPTOMATIC 
 
SYMPTOMS 
1-VAGINAL DISCHARGE 
2-ITCHING 
3-DYSPAREUNIA 
4-LOWER ABDOMINAL PAIN 
5-GROWTH/SWELLING 
6-ULCER 
7-DISCHARGE + LAP 
8-DISCHARGE + ITCHING 
9-ITCHING + LAP 
 
EXTERNAL GENITALIA 
1-NORMAL 
2-GROWTH 
3-ULCER 
 
DISCHARGE AMOUNT 
1-SCANTY 
2-MODERATE 
3-PROFUSE 
 
  
 DISCHARGE COLOR 
1-WHITE 
2-GRAY 
3-YELLOW 
4-GREENISH 
 
DISCHARGE CONSISTENCY 
1-FLOCCULAR 
2-MUCOPURULENT 
3-HOMOGENOUS 
4-CURDY 
5-FROTHY 
 
DISCHARGE ODOUR 
1-ODOURLESS 
2-FOUL SMELL 
3-FISHY ODOUR 
 
CERVICAL EXAMINATION 
1-NORMAL 
2-EROSION 
3-ERYTHEMA 
4-NOT EXAMINED 
 
WHIFF TEST 
P-POSITIVE 
N-NEGATIVE 
 
  
CLUE CELLS 
1-NO CLUE CELLS 
2-CLUE CELLS>20% 
3-CLUE CELLS<20% 
 
WET MOUNT 
1-NORMAL 
2-CLUE CELLS 
3-TV 
 
KOH MOUNT 
1-NORMAL 
2-BUDDING YEAST CELLS 
 
FINAL DIAGNOSIS 
 BV - BACTERIAL VAGINOSIS 
 TV -TRICHOMONAS VAGINALIS 
 CANDIDA - CANDIDIASIS  
 HIV - HUMAN IMMUNODEFICIENCY VIRUS 
  
PROFORMA 
 
Name: 
Age/ Sex: 
OP no/ Hospital ID no: 
Occupation: 
Address: 
 
Socioeconomic status: 
 
Complaints: 
 
H/o present illness: 
 
H/o vaginal / urethral discharge: 
H/o abdominal pain: 
H/o dyspareunia: 
H/o pruritus: 
 
Menstrual history: 
LMP: 
Regular /irregular: 
 
Marital History:  
Single/ married/ divorced/ widow 
Living together or alone: 
 
  
Obstetric history: 
Normal delivery/LSCS 
 
Sexual history: 
Last marital contact: 
Premarital contact: 
Extra marital contact: 
Condom use: 
 
Previous history suggestive of STI:  
If yes 
Genital ulcer: 
Genital discharge: 
Others: 
Treated /untreated: 
 
Husband with pre/extra marital contact: 
 
Past History: 
Tuberculosis: 
Diabetes: 
Hypertension: 
Bronchial asthma: 
Previous surgeries: 
Blood transfusions: 
Jaundice: 
  
 Family History: 
Personal History: 
IV drug abuse  
Aberrant sexual practice 
 
General examination: 
Built: 
Pallor: 
Jaundice: 
Pedal edema: 
Generalised lymphadenopathy: 
Pulse: 
BP: 
 
Systemic examination: 
CVS: 
RS: 
Abdomen: 
CNS: 
 
Local examination: 
Female: 
Any significant inguinal lymphadenopathy: 
Inspection: 
Vaginal discharge: 
Any genital abnormalities: 
Per vaginal examination:  Position of cervix and uterus 
                                         Cervical motion tenderness 
  
Per speculum examination: 
                                        Cervical discharge 
                                        Cervical erosion 
Skin: 
Mucosa: 
Bones and Joints: 
Investigations 
 
Vaginal / cervical discharge:  
Vaginal pH- 
Whiff test- 
Grams stain- 
Wet mount with normal saline-  
 Wet mount with KOH- 
 
Ulcers/erosions:  
Tzanck smear/ Dark field microscopy/ Grams stain 
 
Cervical swab for gonococci culture: 
Blood for VDRL and HIV test: 
  
 AMSEL’S CRITERIA 
 
             Criteria           Present         Absent  
Homogenous vaginal 
discharge 
  
Vaginal pH    > 4.5    
Whiff test   
Clue cell (>20% )   
 
 
NUGENT’S SCORE 
 
Bacterial morphological type 
                                 Score  
None      1+     2+     3+   4+ 
Lactobacilli type 
(large, gram positive rods) 
 
 
  4 
 
  
  3 
 
    
2 
 
   
   1 
 
   
   0 
Gardnerella / Prevotella species 
(small gram negative or variable 
rods) 
 
 
  0 
 
 
    1 
 
 
   2 
 
 
   3 
 
 
   4 
Mobiluncus species 
(curved gram negative or variable 
rods) 
 
 
   0 
 
 
     1 
 
 
    2 
 
 
    3 
 
 
   4 
                    
 
  
 Interpretation: 
< 1 / oil immersion field -         1+ 
1-5 / oil immersion field-          2+ 
6-30/ oil immersion field-         3+ 
>30/ oil immersion field-          4+ 
Score: 
0-3   - Normal 
4-6   - Intermediate 
7-10- Bacterial Vaginosis 
 
Diagnosis: 
Clinical : 
 
Etiological : 
  
CONSENT FORM 
Title of the study:   
“TO STUDY THE EFFICACY OF AMSEL’S CRITERIA & NUGENT’S SCORE 
IN DIAGNOSING BACTERIAL VAGINOSIS AMONG FEMALE PATIENTS 
ATTENDING THE STD CLINIC”. 
 
Name of the participant: 
Name of the principal investigator : Dr. S.Abirami 
Name of the Institution  : Institute of Venereology,  
     Madras Medical College & Rajiv  
     Gandhi Government General Hospital, Chennai –3. 
 
 Documentation of the informed consent:  
 
  I  ---------------------- have read the information in this form (or it has been read to me). 
I was free to ask any questions and they have been answered. I am over 18 years of age 
and exercising my free power of choice, hereby consent to be included as a participant in 
the study. 
1. I have read and understood this consent form and the information provided to me 
2. I have had the consent document explained to me 
3. I have been explained about the nature of the study 
4. My rights and responsibilities have been explained to me by the investigator 
5. I agree to co operate with the investigator and I will inform him/her immediately if I 
suffer unusual symptoms 
6. I have not participated in any research study at any time 
7. I am unaware of the fact that I can opt out of the study at any time without having to 
give any reason and this will not affect my future treatment in this hospital 
8. I hereby give permission to the investigator to release the information obtained from 
me as a result of participation in this study to the sponsors, regulatory authorities, 
Government agencies and institutional ethics committee. I understand that they are 
publicly presented. 
9. My identity will be kept confidential if my data are publicly presented 
10. I am aware that if I have any question during the study, I should contact at one of the 
addresses listed above. By signing this consent form I attest that the information given in 
this document has been clearly explained to me and apparently understood by me, I will 
b given a copy of this consent document.  
 
 Participant initials: 
 
For adult participants: 
 
Name and signature/ thumb impression of the participant (or legal representative if 
participant incompetent) 
 
_________             __________________                    ----------------- 
Name                        Signature                                      Date 
 
Name and signature of impartial witness (required for illiterate patients): 
 
___________           _______________                          _____________ 
Name                          Signature                                       Date 
Address and contact number of the impartial witnesss : 
 
 
Name and signature of the investigator or his representative obtaining consent:  
 
__________________              ______________________               ___________ 
Name                                          Signature                                          Date 
  
INFORMATION SHEET 
                        
“TO STUDY THE EFFICACY OF AMSEL’S CRITERIA & NUGENT’S SCORE 
IN DIAGNOSING BACTERIAL VAGINOSIS AMONG FEMALE PATIENTS 
ATTENDING THE STD CLINIC”. 
 
Name of the participant : 
Name of the principal investigator  : Dr. S.Abirami 
Name of the Institution  : Institute of Venereology,  
     Madras Medical College & Rajiv  
     Gandhi Government General Hospital, Chennai – 
3. 
 
• We are conducting a study on bacterial vaginosis detection among female 
patients attending Rajiv Gandhi Government General Hospital, Chennai. 
• The purpose of this study is to compare the Amsel’s criteria & Nugent’s score in 
diagnosing  Bacterial vaginosis. 
• The privacy of the patients in the research will be maintained throughout the 
study. In the event of any publication or presentation resulting from the research, 
no personally identifiable information will be shared. 
• Taking part in this study is voluntary. You are free to decide whether to 
participate in this study or to withdraw at any time; your decision will not result 
in any loss of benefits to which you are otherwise entitled. 
• The results of the special study may be intimated to you at the end of the study 
period or during the study if anything is found abnormal which may aid in the 
management or treatment. 
 
 
Signature of investigator                                                        Signature of participant 
Date: 
  
 
